Cargando…
Somatic evolution of head and neck cancer — Biological robustness and latent vulnerability
Despite recent advancements in multidisciplinary treatments, the overall survival and quality of life of patients with advanced head and neck squamous cell carcinoma (HNSCC) have not improved significantly over the past decade. Molecular targeted therapies, which have been addressed and advanced by...
Autores principales: | Masuda, Muneyuki, Toh, Satoshi, Wakasaki, Takahiro, Suzui, Masumi, Joe, Andrew K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528403/ https://www.ncbi.nlm.nih.gov/pubmed/23168041 http://dx.doi.org/10.1016/j.molonc.2012.10.009 |
Ejemplares similares
-
Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG—The Role of EGFR Signaling and “Lipid Raft”
por: Masuda, Muneyuki, et al.
Publicado: (2011) -
The Roles of JNK1 and Stat3 in the Response of Head and Neck Cancer Cell Lines to Combined Treatment with All trans‐retinoic Acid and 5‐Fluorouracil
por: Masuda, Muneyuki, et al.
Publicado: (2002) -
Transmanubrial Approach for Removing a Head and Neck Tumor Located at the Upper Lateral Mediastinum
por: Masuda, Muneyuki, et al.
Publicado: (2017) -
Utility of chemoradioselection for the optimization of treatment intensity in advanced hypopharyngeal and laryngeal carcinoma
por: Masuda, Muneyuki, et al.
Publicado: (2017) -
Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wakasaki, Takahiro, et al.
Publicado: (2020)